Aerobic interval training protects against myocardial infarction-induced oxidative injury by enhancing antioxidase system and mitochondrial biosynthesis

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 3, 2014, Pages 192-201

  Jiang, Hong Ke ^a,b   Miao, Yi ^a   Wang, You Hua ^a   Zhao, Mei ^a   Feng, Zhi Hui ^a   Yu, Xiao Jiang ^a   Liu, Jian Kang ^a   Zang, Wei Jin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NANYANG INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Aerobic interval training; Anti oxidase; Mitochondrial biogenesis; Myocardial infarction; Phosphatidylinositol 3 kinase Akt signalling; Sirtuin 3

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CATALASE; GLUTAMATE CYSTEINE LIGASE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MANGANESE SUPEROXIDE DISMUTASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SIRTUIN 3; TRANSCRIPTION FACTOR NRF2;

AEROBIC EXERCISE; AEROBIC INTERVAL TRAINING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MYOCARDIAL INFARCTION; HEART DISEASE; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; MITOCHONDRIAL DYNAMICS; MUSCLE TRAINING; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

AEROBIC INTERVAL TRAINING; ANTI-OXIDASE; MITOCHONDRIAL BIOGENESIS; MYOCARDIAL INFARCTION; PHOSPHATIDYLINOSITOL 3-KINASE/AKT SIGNALLING; SIRTUIN 3;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIOXIDANTS; MALE; MITOCHONDRIA; MITOCHONDRIAL TURNOVER; MYOCARDIAL INFARCTION; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIRTUIN 3;

EID: 84896352484     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12211     Document Type: Article

References (56)

1. Krumholz HM, Wang Y, Chen J et al. Reduction in acute myocardial infarction mortality in the United States: Risk-standardized mortality rates from 1995-2006. JAMA 2009; 302: 767-73.
2. Hung J, Teng TH, Finn J et al. Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: A population-based study of 20, 812 patients with first acute myocardial infarction in Western Australia. J. Am. Heart Assoc. 2013; 2: e000172.
3. Velagaleti RS, Pencina MJ, Murabito JM et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008; 118: 2057-62.
4. Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 2009; 81: 457-64.
5. Schenkel PC, Tavares AM, Fernandes RO et al. Time course of hydrogen peroxide-thioredoxin balance and its influence on the intracellular signalling in myocardial infarction. Exp. Physiol. 2012; 97: 741-9.
6. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med. Sci. Monit. 2009; 15: RA209-19.
7. Copple IM, Goldring CE, Kitteringham NR, Park BK. The Nrf2-Keap1 defence pathway: Role in protection against drug-induced toxicity. Toxicology 2008; 246: 24-33.
8. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am. J. Physiol. Renal. Physiol. 2010; 298: F662-71.
9. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis. The central role of PGC-1alpha. Cardiovasc. Res. 2008; 79: 208-17.
10. Zhu L, Liu Z, Feng Z et al. Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells. J. Nutr. Biochem. 2010; 21: 1089-98.
11. Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: A systematic review and meta-analysis of randomized controlled trials. Am. Heart J. 2011; 162: 571-84.
12. Ellison GM, Waring CD, Vicinanza C, Torella D. Physiological cardiac remodelling in response to endurance exercise training: Cellular and molecular mechanisms. Heart 2012; 98: 5-10.
13. Bo H, Zhang Y, Ji LL. Redefining the role of mitochondria in exercise: A dynamic remodeling. Ann. N.Y. Acad. Sci. 2010; 1201: 121-8.
14. Wisloff U, Stoylen A, Loennechen JP et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation 2007; 115: 3086-94.
15. Fu TC, Wang CH, Lin PS et al. Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int. J. Cardiol. 2013; 167: 41-50.
16. Molmen-Hansen HE, Stolen T, Tjonna AE et al. Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients. Eur. J. Prev. Cardiol. 2012; 19: 151-60.
17. Tjonna AE, Lee SJ, Rognmo O et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: A pilot study. Circulation 2008; 118: 346-54.
18. Poelkens F, Hopman MT, Tack CC. Letter by Poelkens et al. regarding article, 'Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: A pilot study'. Circulation 2009; 119: e225.
19. 2+ cycling by phosphorylation of CaMKII and Thr-17 of phospholamban. J. Mol. Cell. Cardiol. 2007; 43: 354-61.
20. 2+ handling in atrial myocytes from rats with post infarction heart failure. PLoS ONE 2013; 8: e66288.
21. Kraljevic J, Marinovic J, Pravdic D et al. Aerobic interval training attenuates remodelling and mitochondrial dysfunction in the post-infarction failing rat heart. Cardiovasc. Res. 2013; 99: 55-64.
22. Haram PM, Kemi OJ, Lee SJ et al. Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. Cardiovasc. Res. 2009; 81: 723-32.
23. Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc. Res. 2009; 81: 449-56.
24. Someya S, Yu W, Hallows WC et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143: 802-12.
25. Liu J, Shen W, Zhao B et al. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients. Adv. Drug Deliv. Rev. 2009; 61: 1343-52.
26. Piepoli MF, Conraads V, Corra U et al. Exercise training in heart failure: From theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur. J. Heart Fail. 2011; 13: 347-57.
27. Smart NA, Haluska B, Jeffriess L, Leung D. Exercise training in heart failure with preserved systolic function: A randomized controlled trial of the effects on cardiac function and functional capacity. Congest. Heart Fail. 2012; 18: 295-301.
28. Fletcher GF, Balady GJ, Amsterdam EA et al. Exercise standards for testing and training: A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-740.
29. Wisloff U, Brubakk AO. Aerobic endurance training reduces bubble formation and increases survival in rats exposed to hyperbaric pressure. J. Physiol. 2001; 537: 607-11.
30. Seiler S, Joranson K, Olesen BV, Hetlelid KJ. Adaptations to aerobic interval training: Interactive effects of exercise intensity and total work duration. Scand. J. Med. Sci. Sports 2013; 23: 74-83.
31. Haigis MC, Guarente LP. Mammalian sirtuins: Emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006; 20: 2913-21.
32. Tan WQ, Wang K, Lv DY, Li PF. Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J. Biol. Chem. 2008; 283: 29730-9.
33. Choudhury M, Jonscher KR, Friedman JE. Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat. Aging 2011; 3: 175-8.
34. Hirschey MD, Shimazu T, Goetzman E et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010; 464: 121-5.
35. Gurd BJ, Holloway GP, Yoshida Y, Bonen A. In mammalian muscle, SIRT3 is present in mitochondria and not in the nucleus; and SIRT3 is upregulated by chronic muscle contraction in an adenosine monophosphate-activated protein kinase-independent manner. Metabolism 2012; 61: 733-41.
36. Zhu H, Itoh K, Yamamoto M, Zweier JL, Li Y. Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: Protection against reactive oxygen and nitrogen species-induced cell injury. FEBS Lett. 2005; 579: 3029-36.
37. Muthusamy VR, Kannan S, Sadhaasivam K et al. Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium. Free Radic. Biol. Med. 2012; 52: 366-76.
38. Rasul A, Ding C, Li X et al. Dracorhodin perchlorate inhibits PI3K/Akt and NF-kappaB activation, up-regulates the expression of p53, and enhances apoptosis. Apoptosis 2012; 17: 1104-19.
39. Choi YJ, Kim DH, Lee EK et al. Attenuation of age-related changes in FOXO3a activity and the PI3K/Akt pathway by short-term feeding of ferulate. Age 2012; 34: 317-27.
40. Wu KL, Wu CA, Wu CW, Chan SH, Chang AY, Chan JY. Redox-sensitive oxidation and phosphorylation of PTEN contribute to enhanced activation of PI3K/Akt signaling in rostral ventrolateral medulla and neurogenic hypertension in spontaneously hypertensive rats. Antioxid. Redox Signal. 2013; 18: 36-50.
41. Arslan F, Lai RC, Smeets MB et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013; 10: 301-12.
42. Cheng XW, Kuzuya M, Kim W et al. Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Akt-dependent hypoxia-induced factor-1 alpha reactivation in mice of advanced age. Circulation 2010; 122: 707-16.
43. Cheng SM, Ho TJ, Yang AL et al. Exercise training enhances cardiac IGFI-R./PI3K/Akt and Bcl-2 family associated pro-survival pathways in streptozotocin-induced diabetic rats. Int. J. Cardiol. 2013; 167: 478-85.
44. Deldicque L, Theisen D, Francaux M. Regulation of mTOR by amino acids and resistance exercise in skeletal muscle. Eur. J. Appl. Physiol. 2005; 94: 1-10.
45. Karamanlidis G, Nascimben L, Couper GS, Shekar PS, del Monte F, Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ. Res. 2010; 106: 1541-8.
46. Naudi A, Jove M, Ayala V et al. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress. Exp. Diabetes Res. 2012; 2012: 696215.
47. Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J. Appl. Physiol. 2011; 111: 1066-71.
48. Heather LC, Carr CA, Stuckey DJ et al. Critical role of complex III in the early metabolic changes following myocardial infarction. Cardiovasc. Res. 2010; 85: 127-36.
49. Reznick RM, Shulman GI. The role of AMP-activated protein kinase in mitochondrial biogenesis. J. Physiol. 2006; 574: 33-9.
50. Wang Y, Wang S, Wier WG et al. Exercise improves the dilatation function of mesenteric arteries in postmyocardial infarction rats via a PI3K/Akt/eNOS pathway-mediated mechanism. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H2097-106.
51. Cieslik KA, Taffet GE, Crawford JR, Trial J, Mejia Osuna P, Entman ML. AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J. Mol. Cell. Cardiol. 2013; 63: 26-36.
52. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006; 12: 459-65.
53. He X, Zhang HL, Zhao M et al. Amlodipine ameliorates endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2011; 38: 255-61.
54. Gong K, Li W. Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. Free Radic. Biol. Med. 2011; 51: 2259-71.
55. Myhre O, Andersen JM, Aarnes H, Fonnum F. Evaluation of the probes 2′, 7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem. Pharmacol. 2003; 65: 1575-82.
56. Wang JXX, Jiang H, Xie JX. Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem. Pharmacol. 2009; 78: 178-83.